NasdaqGM - Nasdaq Real Time Price USD

LeMaitre Vascular, Inc. (LMAT)

82.68
+2.28
+(2.84%)
As of 2:04:34 PM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 59.87M
Earnings 11.01M

Q2'24

Q3'24

Q4'24

Q1'25

0
20M
40M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

90.00
104.50 Average
82.68 Current
120.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 9999
Avg. Estimate 0.570.542.152.38
Low Estimate 0.550.52.12.26
High Estimate 0.580.562.182.52
Year Ago EPS 0.520.491.932.15

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 11111111
Avg. Estimate 62.48M60.75M245.47M267.1M
Low Estimate 61.5M59M242.37M256M
High Estimate 63.11M61.95M247.89M277.63M
Year Ago Sales 55.85M54.82M219.86M245.47M
Sales Growth (year/est) 11.88%10.81%11.65%8.81%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. 0.470.430.490.5
EPS Actual 0.520.490.490.48
Difference 0.050.06-0-0.02
Surprise % 10.30%13.29%-0.68%-3.57%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.570.542.152.38
7 Days Ago 0.580.562.232.46
30 Days Ago 0.580.562.242.47
60 Days Ago 0.580.562.242.47
90 Days Ago 0.570.532.172.39

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1------
Up Last 30 Days 1------
Down Last 7 Days 4553
Down Last 30 Days 4553

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
LMAT 8.76%9.75%11.51%10.79%
S&P 500 13.08%2.49%7.56%13.96%

Upgrades & Downgrades

Maintains Lake Street: Buy to Buy 2/28/2025
Maintains Citizens Capital Markets: Buy to Buy 2/28/2025
Downgrade Barrington Research: Outperform to Market Perform 2/28/2025
Initiated Wells Fargo: Equal-Weight 2/13/2025
Reiterates Oppenheimer: Outperform to Outperform 11/1/2024
Maintains Barrington Research: Outperform to Outperform 11/1/2024

Related Tickers